Ovid Therapeutics Inc.OVIDNASDAQ
Loading
EBITDA Over TimeContracting
Percentile Rank64
Studio
Year-over-Year Change

Earnings before interest, taxes, depreciation, and amortization

Latest
$-42.44M
↓ 15% vs avg
Percentile
P64
Within normal range
Streak
1 yr
Consecutive growthContracting
Average
$-36.92M
Historical baseline
PeriodValueYoY Change
2025$-42.44M+26.5%
2024$-57.77M-1.3%
2023$-57.01M-5.3%
2022$-54.17M-143.5%
2021$124.45M+253.4%
2020$-81.12M-32.7%
2019$-61.15M-15.8%
2018$-52.79M+18.4%
2017$-64.73M-187.9%
2016$-22.48M-